相关实验视频

Updated: Jun 15, 2025

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Published on: September 13, 2013

通过Talquetamab识别GPRC5D的结构基础,这是多发性髓瘤的双特异抗体

Jihong Jeong¹, Junhyeon Park¹, Geun Young Mo¹

¹Department of Life Sciences, Pohang University of Science and Technology, Pohang, Kyungbook 37673, South Korea.

Journal of molecular biology

|August 24, 2024

概括

结构洞察力揭示了双特异性抗体talquetamab如何在多发性骨髓瘤中准GPRC5D. 这一发现有助于开发针对复发性或耐药性疾病的改进免疫疗法.

科学领域:

生物化学生化学
免疫学免疫学免疫学
结构生物学结构生物学

背景情况:

多发性骨髓瘤 (MM) 是一种血细胞恶性瘤,常常具有耐治疗性.
G蛋白结合受体类C组5组成员D (GPRC5D) 是MM中一个有前途的免疫治疗标.
塔尔基塔马布是一种FDA批准的双特异性抗体,针对MM治疗的GPRC5D.

研究的目的:

阐明talquetamab.通过GPRC5D识别的结构基础.
为优化针对GPRC5D的基于抗体的疗法提供见解.

主要方法:

使用冷电子显微镜 (cryo-EM) 来确定GPRC5D-talquetamab Fab复合物的结构.
对抗体与GPRC5D同位体之间的相互作用接口的分析.

主要成果:

结构显示GPRC5D形成了一个对称的同位体.
塔尔克塔马布的Fab片段与GPRC5D二次体结合,与细胞外循环和跨膜螺旋连接多个互补性确定区域 (CDR).
塔尔克塔马布中的一种特定的氨酸残留物与GPRC5D细胞外表面的口袋相互作用.

结论:

确定的结构提供了对GPRC5D-talquetamab相互作用的分子理解.
这些见解可以指导下一代针对多发性骨髓瘤的GPRC5D向抗体的设计.
这项研究支持开发针对复发性或耐火性MM的新型免疫疗法.

关键词:

在GPRC5D中使用.多发性骨髓瘤是一种多发性骨髓瘤.在C类GPCR中,GPCR是C类的.化-EM结构的结构.我们谈论的是什么.

更多相关视频

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

相关概念视频

Transducer Mechanism: G Protein–Coupled Receptors

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

GPCR Desensitization

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...